Literature DB >> 9930053

Impact of stenting on coronary angioplasty procedures.

H S Lee1, C Densem, R D Levy, D H Bennett, S G Ray, N H Brooks.   

Abstract

OBJECTIVE: To compare patient selection and outcome of coronary angioplasty procedures before and after the widespread availability and use of stents. SUBJECTS AND METHODS: Group 1 consisted of 252 consecutive patients and group 2 comprised 389 patients who underwent angioplasty between April 1993 and March 1994, and April 1995 and March 1996, respectively, in a tertiary cardiothoracic centre. Clinical variables were collected before the procedures. Endpoints included in-hospital death, the need for repeat coronary angiography, repeat angioplasty, and coronary artery bypass surgery. Lesions were classified under American Heart Association/American College of Cardiology criteria in 100 randomly selected patients from each group.
RESULTS: 311 and 482 angioplasty procedures were performed in patients from groups 1 and 2, respectively. One or more stents were deployed in nine (4%) and 179 (46%, p < 0.01) patients, respectively. The success rate was higher in group 2 than in group 1 patients (483/523 (92%) v 274/372 (88%), respectively, p < 0.05). There were significantly more single vessel angioplasty procedures (198/252 (79%) v 272/389 (70%), p < 0.05), type A lesions (30/116 (26%) v 19/130 (15%), p < 0.05), patients with stable angina (220/252 (87%) v 311/389 (80%), p < 0.05), and fewer acute myocardial infarction patients (1/252 (0%) v 12/389 (3%), p < 0.05) treated in group 1 than in group 2, respectively. Similar numbers of angioplasty were performed in the left anterior descending, left circumflex, and right coronary arteries. There were no significant differences in the in-hospital mortality or the need for repeat coronary angiography, angioplasty, or bypass surgery at 24 hours or six months after the initial procedure.
CONCLUSION: Patients undergoing angioplasty in the stenting era had features associated with an increased risk of complication. Despite this, the primary success rate was higher, and the complication rate and the need for subsequent revascularisation were similar in the two groups, supporting the widely held clinical impression that stenting has made a valuable impact on the practice of angioplasty.

Entities:  

Mesh:

Year:  1998        PMID: 9930053      PMCID: PMC1728832          DOI: 10.1136/hrt.80.5.505

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

1.  Caveats about elective coronary stenting.

Authors:  E J Topol
Journal:  N Engl J Med       Date:  1994-08-25       Impact factor: 91.245

2.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1988-08       Impact factor: 24.094

3.  NHLBI funding policies. Enhancing stability, predictability, and cost control.

Authors:  C Lenfant
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

4.  Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

Authors:  G Schuler; R Hambrecht; G Schlierf; J Niebauer; K Hauer; J Neumann; E Hoberg; A Drinkmann; F Bacher; M Grunze
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

5.  Complications and follow-up after intracoronary stenting: critical analysis of a 6-year single-center experience.

Authors:  E Eeckhout; J J Goy; P Vogt; J C Stauffer; U Sigwart; L Kappenberger
Journal:  Am Heart J       Date:  1994-02       Impact factor: 4.749

6.  In-hospital costs associated with new percutaneous coronary devices.

Authors:  R J Dick; J J Popma; D W Muller; K A Burek; E J Topol
Journal:  Am J Cardiol       Date:  1991-10-01       Impact factor: 2.778

7.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.

Authors:  P W Serruys; P de Jaegere; F Kiemeneij; C Macaya; W Rutsch; G Heyndrickx; H Emanuelsson; J Marco; V Legrand; P Materne
Journal:  N Engl J Med       Date:  1994-08-25       Impact factor: 91.245

8.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.

Authors:  D L Fischman; M B Leon; D S Baim; R A Schatz; M P Savage; I Penn; K Detre; L Veltri; D Ricci; M Nobuyoshi
Journal:  N Engl J Med       Date:  1994-08-25       Impact factor: 91.245

9.  In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.

Authors:  D J Cohen; H M Krumholz; C A Sukin; K K Ho; R B Siegrist; M Cleman; R R Heuser; J A Brinker; J W Moses; M P Savage
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

10.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.

Authors:  U Sigwart; J Puel; V Mirkovitch; F Joffre; L Kappenberger
Journal:  N Engl J Med       Date:  1987-03-19       Impact factor: 91.245

View more
  1 in total

1.  Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period.

Authors:  J P Pell; D Walsh; J Norrie; G Berg; A D Colquhoun; K Davidson; H Eteiba; A Faichney; A Flapan; K J Hogg; R R Jeffrey; K Jennings; J McArthur; P Mankad; K Oldroyd; A C Pell; I R Starkey
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.